News About: Pharm. Industry
The Hanmi’s Esomezol has tasted bitterness in the U.S. market, but learned somethingAmneal, taking charge of the sale right of the Hanmi Pharm’s reflux esophagitis treatment, Esomezol(esomeprazole strontium), has practically stopped its distribution in a year a...
|
Merck Korea changes corporate names of its corporatesMerck Korea, a healthcare and life science company, finished successful mergers and has begun to change its corporate name.
According to the company, among the total 4 corporat...
|
As Synageva is taken over by Alexion, its entry to the domestic market become vagueThe American pharmaceutical company, Synageva, has encountered difficulties in expansion to the Korean market.
According to the industry concerned on the 24th, a pharmaceutical...
|
The Joint Treatment Act of Clinic-Level Doctors, Dentists and Oriental Doctors has been withdrawn
The Pharmaceutical Law Amendment, which approves joint treatments by establishment of clinic-level medical institutions for doctors, dentists and oriental doctors in a single place, has been withdrawn.
According to t...
The 2014 pharmaceutical manufacturing performance was KRW 16.4 trillion while ‘Hanmi Pharm’ ranked the firstLast year, pharmaceutical manufacturing performance recorded KRW 16.4 trillion. The Ministry of Food and Drug Safety (Ministry Seung-hee Kim) unveiled that domestic pharmaceutic...
|
Amgen appointed the former Bayer president, Sang-gyeong Roh, as the president of its Korean branchThe multinational biopharmaceutical company, Amgen, appointed the former president of Bayer Ethical Drug department, Sang-gyeong Roh, to expand to the domestic market.
Accordin...
|
“The domestic CRO industry, ignored by both the pharmaceutical industry and the government, needs earnest supports”
The Korea Contract Research Organization(CRO) Association signaled development of the domestic CRO industry by its launch as an affiliated corporate of the Ministry of Commerce, Industry and Energy.
The Korea CRO Ass...
Domestic pharmaceutical companies have poured out 42 generics of Baraclude just in this year
Domestic pharmaceutical companies have shown interests in type B hepatitis treatments.
According to the Ministry of Food and Drug Safety, generics of ‘Baraclude (entecavir),’ which were first introduced by BMS Korea ...
Green Cross Holdings invested in an American bio venture to develop gene therapyGreen Cross Holdings (President Byung-geon Lee) announced on the 14th that it has participated in the Series B-2 Round of the American bio venture ‘Juventas Therapeutics(hereina...
|
Why did Takeda select GeoYoung and Dongwon Pharmaceutical Wholesale?As launching Actinum, Takeda has come forward with distribution not with domestic pharmaceutical companies, but typical wholesalers such as GeoYoung and Dongwon Pharmaceutical W...
|
